Avoro Capital Advisors LLC - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 142 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
Avoro Capital Advisors LLC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$100,092,000
+81.0%
5,700,0000.0%1.57%
+63.4%
Q2 2021$55,290,000
-9.7%
5,700,0000.0%0.96%
-9.0%
Q1 2021$61,218,000
-28.2%
5,700,000
-1.7%
1.06%
-28.0%
Q4 2020$85,318,000
+9.2%
5,800,000
+5.5%
1.47%
+32.3%
Q3 2020$78,155,000
+103.4%
5,500,000
+15.8%
1.11%
+46.1%
Q2 2020$38,428,000
+92.2%
4,750,000
-4.0%
0.76%
+12.6%
Q1 2020$19,998,000
+1329.4%
4,950,000
+2076.8%
0.68%
+277.1%
Q1 2017$1,399,000
+8.9%
227,3990.0%0.18%
-31.2%
Q4 2016$1,285,000
-72.5%
227,399
-28.0%
0.26%
-68.3%
Q3 2016$4,671,000
+127.4%
316,020
+38.2%
0.82%
+79.8%
Q2 2016$2,054,000
-2.9%
228,6970.0%0.46%
-38.2%
Q1 2016$2,115,000
-33.9%
228,697
-9.9%
0.74%
-33.0%
Q4 2015$3,199,000
-4.5%
253,697
-0.5%
1.10%
+26.5%
Q3 2015$3,351,000
+62.7%
255,097
+170.2%
0.87%
+53.6%
Q2 2015$2,060,000
-36.3%
94,400
-41.3%
0.57%
-54.3%
Q1 2015$3,234,000160,6971.24%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
VR Adviser, LLC 4,040,000$59,428,0008.74%
Fairmount Funds Management LLC 1,478,181$21,744,0007.78%
COMMODORE CAPITAL LP 852,871$12,546,0006.82%
Ghost Tree Capital, LLC 1,950,000$28,685,0006.39%
Endurant Capital Management LP 655,741$9,646,0003.48%
FRAZIER MANAGEMENT LLC 3,053,107$44,879,0003.46%
ACUTA CAPITAL PARTNERS, LLC 803,000$11,812,0003.21%
NEA Management Company, LLC 5,736,363$84,382,0002.23%
Tri Locum Partners LP 296,838$4,366,0001.59%
Avidity Partners Management LP 3,185,200$46,854,0001.52%
View complete list of TRILLIUM THERAPEUTICS INC shareholders